Bayer AGOvjeren akaunt

@Bayer

Advancing life - that's what we at Bayer are all about. Data Privacy Statement / Imprint:

Leverkusen
Vrijeme pridruživanja: travanj 2010.

Medijski sadržaj

  1. 4. velj

    It's the 2nd leading cause of death worldwide, and it affects more than 32 million people. Today on , we've looked at the history of cancer and how we can fight it. Find out here:

  2. 4. velj

    After Ray Park went into pension he started fighting prostate cancer. Today, he explains his journey and how the Bayer foundation has helped him learn how to live with cancer. Read his story:

  3. 4. velj

    We have been listed as a leading international company for water management by the renowned rating organization . We are proud that we have received the highest rating “A” in 2019. At the same time, it motivates us to ramp up our efforts:

  4. 30. sij

    Today the young entrepreneurs in met the employees of our campaign . Together they discussed what motivates them to find solutions for advancing life. A lot of enthusiasm for new ideas was in the air!

  5. 30. sij

    Neglected tropical diseases are a group of preventable, treatable diseases that can rob people of their , livelihood & sense of dignity. Find out how our new formulation of medicine will help :

  6. 28. sij
    Odgovor korisniku/ci
  7. 28. sij

    Bayer to donate medicines and money with a total value of approximately EUR 1.5 million to combat in China. “We want to help people in the affected regions quickly and effectively.” CEO Werner Baumann

  8. 24. sij

    Public trust in large businesses is decreasing. At & 's event, our CEO Werner Baumann explained that he sees this as an opportunity to rebuild trust by taking action. That's why we aim to help achieve the :

  9. 21. sij

    Score! 💪 Germany has taken first place in the new Index! How? Of the 20 listed companies with the highest R&D expenditure, four came from Germany, one being Bayer:

  10. 21. sij

    Can be intrinsically good or bad? It’s about how it is put to use. That's why our CEO Werner Baumann calls for proper regulations and . Watch today's discussion on the challenges and opportunities of genome editing:

  11. 20. sij

    What can we contribute in the areas of climate protection, and ? Our CEO Werner Baumann and President Liam Condon will discuss these topics this week. Stay tuned to the upcoming event livestreams!

  12. 20. sij

    We have been listed as a leading international company in the climate category by the renowned rating organization since 2005. We are proud that we have received the highest rating “A” in 2019. At the same time, it motivates us to ramp up our efforts:

  13. 14. sij

    With we push beyond what is considered possible and explore radically new approaches in the life sciences. By investing in disruptive technologies we want to help to solve some of the world's biggest challenges. Find out more:

  14. 10. sij

    Skin-friendly bacteria, known as microbiome, could soon become a source for . We're partnering with to harness their potential for new natural skin care products for sensitive and eczema-prone skin. Find out more:

  15. 10. sij

    In many ways, developing a new drug is like running a marathon - for a decade. Using algorithms can help speed up the process. Find out how computer analysts use in drug development:

  16. 9. sij

    Want to know how can help to transform patient health? Our experts and Abel Archundia explained at the in Berlin:

  17. 8. sij

    Although much progress has been made, there still remain significant challenges to treating . Dr. Alan Cuthbertson and his team from in Oslo are working on treatments that destroy cancer cells and leave healthy cells unharmed:

  18. 7. sij

    Destroying cancer cells, leaving healthy cells unharmed: Find out how Alan Cuthbertson from is combining tumor-specific antibodies with alpha radiation-emitting agents:

  19. 1. sij

    We wish everyone a happy and healthy year in #2020 and a great start into the new decade.

  20. 26. pro 2019.

    Treating advanced is a race against time, because some products used in therapy have a shelf-life of only 28 days. Ingo Ocklenburg, Global Strategic Sourcing Manager, Bayer, explains how we can optimize production and delivery:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·